Why Should Early-Stage Biotechs Care about Intellectual Property?Hester Sheehan, Research Scientist at Arctoris, reflects on her IP journey on World Intellectual Property Day.Apr 26, 2021Apr 26, 2021
Early-Stage Drug Discovery and the Importance of High-Quality DataGoodwin-Arctoris Drug Discovery Masterclass RecapMar 25, 2021Mar 25, 2021
COVID in the crosshairs — reflections on developing a collaboration with BMG LabTechDan Thomas, discusses data precision & new partnerships in light of new global health challenges.Mar 4, 2021Mar 4, 2021
Why should you automate your experiments?Guest post by Poppy Roworth, our Head of Laboratory at ArctorisFeb 25, 2021Feb 25, 2021
Arctoris celebrates the International Day of Women and Girls in Science 2021Women of Arctoris reflect on their science idolsFeb 11, 2021Feb 11, 2021
Celebrating Five Years of ArctorisOur co-founders look back on how Arctoris was born and how we got to where we are today.Feb 4, 2021Feb 4, 2021
5 Myths About Laboratory AutomationThese 5 myths stand in the way of embracing automation in the lab. Read more about why they are overestimated and how to overcome them.Jan 28, 2021Jan 28, 2021
Young Scholars at a Young Company: Meet our InternsOur relationship with the University of Oxford starts with our founders who met there while completing their doctorates, and includes the…Jan 14, 2021Jan 14, 2021
2020: A significant year for drug discovery and usA few observations about drug discovery in times that call for more efficiency in the interest of public health.Dec 21, 2020Dec 21, 2020
From Eroom’s Law to Moore’s Law: Drug Discovery in the 21st CenturyThe cost of developing a new drug doubles every 9 years. Learn how automation in drug discovery can reverse this trend.Dec 17, 2020Dec 17, 2020
